Beklometazon dipropionat
Изглед
Klinički podaci | |
---|---|
Prodajno ime | Aerobec, Aldecin, Anceron, Andion |
Drugs.com | dipropionate.html Monografija |
Način primene | Nazalno, respiratorno (inhalacija), topikalno |
Farmakokinetički podaci | |
Poluvreme eliminacije | 2,8 h |
Izlučivanje | Fekalno |
Identifikatori | |
CAS broj | 5534-09-8 |
ATC kod | A07EA07 (WHO), R03BA01 |
PubChem | CID 21700 |
DrugBank | DB00394 |
ChemSpider | 20396 |
KEGG | C07813 |
ChEBI | CHEBI:3002 |
ChEMBL | CHEMBL1200500 |
Hemijski podaci | |
Formula | C28H37ClO7 |
Molarna masa | 521,042 |
| |
| |
Fizički podaci | |
Tačka topljenja | 117—120 °C (243—248 °F) |
Beklometazon dipropionat koji je u prodaji pod imenom Qvar, između ostalih, kortikosteroidni je lek.[1] On je dostupan u inhalacionom obliku, kao kream, pilule, i nazalni sprej.[2] Inhalaciona forma se koristi u dugoročnom tretmanu astme.[1] Krem se može koristiti za lečenje dermatitisa i psorijaze.[3] Pilule se koriste u tretmanu ulcerativnog kolitisa.[4] Nazalni sprej se koristi za tretman alergijskog rinitisa i nazalnih polipa.[5]
Osobine
[уреди | уреди извор]Beklometazon dipropionat je organsko jedinjenje, koje sadrži 28 atoma ugljenika i ima molekulsku masu od 521,042 Da.[6][7][8][9][10][11][12][13][14]
Osobina | Vrednost |
---|---|
Broj akceptora vodonika | 7 |
Broj donora vodonika | 1 |
Broj rotacionih veza | 8 |
Particioni koeficijent[15] (ALogP) | 4,1 |
Rastvorljivost[16] (logS, log(mol/L)) | -6,4 |
Polarna površina[17] (PSA, Å2) | 107,0 |
Reference
[уреди | уреди извор]- ^ а б „Beclomethasone Dipropionate”. The American Society of Health-System Pharmacists. Pristupljeno 2. 12. 2015.
- ^ „List of products: BECLOMETASONE DIPROPIONATE”. MHRA. Pristupljeno 6. 12. 2015.
- ^ „Beclometasone dipropionate 0.25 mg/g Cream” (PDF). MHRA. Pristupljeno 6. 12. 2015.
- ^ „Clipper” (PDF). MHRA. Pristupljeno 6. 12. 2015.
- ^ „Beclomethasone Dipropionate eent”. The American Society of Health-System Pharmacists. Pristupljeno 2. 12. 2015.
- ^ Willey RF, Milne LJ, Crompton GK, Grant IW: Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest. 1976 Jan;70(1):32-8. PMID 1259918
- ^ Salzman GA, Pyszczynski DR: Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol. 1988 Feb;81(2):424-8. PMID 3339197
- ^ Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S: Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol. 2003 Jun;90(6):646-51. PMID 12839324
- ^ Astegiano M, Pagano N, Sapone N, Simondi D, Bertolusso L, Bresso F, Demarchi B, Pellicano R, Bonardi R, Marconi S, Rizzetto M: Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study. Biomed Pharmacother. 2007 Jul;61(6):370-6. Epub 2007 Mar 12. PMID 17399941
- ^ McDonald GB: Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation. Expert Opin Investig Drugs. 2007 Oct;16(10):1709-24. PMID 17922633
- ^ Hockenbery DM, Cruickshank S, Rodell TC, Gooley T, Schuening F, Rowley S, David D, Brunvand M, Berryman B, Abhyankar S, Bouvier M, McDonald GB: A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood. 2007 May 15;109(10):4557-63. Epub 2007 Jan 23. PMID 17244684
- ^ Castilla C, Perez-Simon JA, Sanchez-Guijo FM, Diez-Campelo M, Ocio E, Perez-Persona E, Lopez-Villar O, Vazquez L, Caballero D, San Miguel JF: Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD). Biol Blood Marrow Transplant. 2006 Sep;12(9):936-41. PMID 16920559
- ^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
- ^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889
. PMID 18048412. doi:10.1093/nar/gkm958.
- ^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
- ^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
- ^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
[уреди | уреди извор]- Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
- Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
[уреди | уреди извор]
Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |